"World's Most Complete Market Research Reports Repository"

Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025

This report studies the global Prescription Dermatological Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Prescription Dermatological Drugs market by companies, region, type and end-use industry.

In 2017, the global Prescription Dermatological Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered
Johnson & Johnson
Merck
Bayer
Mylan Pharmaceuticals
Pfizer
F. Hoffmann-La Roche
Allergan
Valeant Pharmaceuticals
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The study objectives of this report are:
To study and forecast the market size of Prescription Dermatological Drugs in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prescription Dermatological Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Prescription Dermatological Drugs Manufacturers
Prescription Dermatological Drugs Distributors/Traders/Wholesalers
Prescription Dermatological Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Prescription Dermatological Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Prescription Dermatological Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Prescription Dermatological Drugs
1.1 Prescription Dermatological Drugs Market Overview
1.1.1 Prescription Dermatological Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Prescription Dermatological Drugs Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Prescription Dermatological Drugs Market by Type
1.3.1 Anti-acne Drugs
1.3.2 Anti-aging Drugs
1.3.3 Dermatitis Drugs
1.3.4 Hair Loss Drugs
1.3.5 Psoriasis Drugs
1.3.6 Skin Cancer Drugs
1.3.7 Melasma Drugs
1.3.8 Seborrhea Drugs
1.4 Prescription Dermatological Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies

2 Global Prescription Dermatological Drugs Competition Analysis by Players
2.1 Prescription Dermatological Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Johnson & Johnson
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.2 Merck
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.3 Bayer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.4 Mylan Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.6 F. Hoffmann-La Roche
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.7 Allergan
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.8 Valeant Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.9 PharmaDerm Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)
3.10 Allergan Inamed Corporation
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Prescription Dermatological Drugs Revenue (Million USD) (2013-2018)

4 Global Prescription Dermatological Drugs Market Size by Type and Application (2013-2018)
4.1 Global Prescription Dermatological Drugs Market Size by Type (2013-2018)
4.2 Global Prescription Dermatological Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Prescription Dermatological Drugs in Future
4.4 Top Consumer/End Users of Prescription Dermatological Drugs

5 United States Prescription Dermatological Drugs Development Status and Outlook
5.1 United States Prescription Dermatological Drugs Market Size (2013-2018)
5.2 United States Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Prescription Dermatological Drugs Market Size by Application (2013-2018)

6 Europe Prescription Dermatological Drugs Development Status and Outlook
6.1 Europe Prescription Dermatological Drugs Market Size (2013-2018)
6.2 Europe Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
6.3 Europe Prescription Dermatological Drugs Market Size by Application (2013-2018)

7 China Prescription Dermatological Drugs Development Status and Outlook
7.1 China Prescription Dermatological Drugs Market Size (2013-2018)
7.2 China Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
7.3 China Prescription Dermatological Drugs Market Size by Application (2013-2018)

8 Japan Prescription Dermatological Drugs Development Status and Outlook
8.1 Japan Prescription Dermatological Drugs Market Size (2013-2018)
8.2 Japan Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
8.3 Japan Prescription Dermatological Drugs Market Size by Application (2013-2018)

9 Southeast Asia Prescription Dermatological Drugs Development Status and Outlook
9.1 Southeast Asia Prescription Dermatological Drugs Market Size (2013-2018)
9.2 Southeast Asia Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Prescription Dermatological Drugs Market Size by Application (2013-2018)

10 India Prescription Dermatological Drugs Development Status and Outlook
10.1 India Prescription Dermatological Drugs Market Size (2013-2018)
10.2 India Prescription Dermatological Drugs Market Size and Market Share by Players (2013-2018)
10.3 India Prescription Dermatological Drugs Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Prescription Dermatological Drugs Market Size (Value) by Regions (2018-2025)
11.1.1 United States Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.2 Europe Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.3 China Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.4 Japan Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.1.6 India Prescription Dermatological Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Prescription Dermatological Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Prescription Dermatological Drugs Market Size by Application (2018-2025)

12 Prescription Dermatological Drugs Market Dynamics
12.1 Prescription Dermatological Drugs Market Opportunities
12.2 Prescription Dermatological Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Prescription Dermatological Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Prescription Dermatological Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Global Prescription Dermatological Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Prescription Dermatological Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Regions (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share by Type in 2017
Figure Anti-acne Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Anti-aging Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Dermatitis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Hair Loss Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Psoriasis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Skin Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Melasma Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Seborrhea Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Application in 2017
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018)
Figure Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2013-2018)
Table Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Johnson & Johnson Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Merck Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Bayer Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Bayer (2013-2018)
Figure Bayer Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Mylan Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Mylan Pharmaceuticals (2013-2018)
Figure Mylan Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Allergan Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Allergan (2013-2018)
Figure Allergan Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Valeant Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2013-2018)
Figure Valeant Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table PharmaDerm Pharmaceuticals Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of PharmaDerm Pharmaceuticals (2013-2018)
Figure PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Allergan Inamed Corporation Basic Information List
Table Prescription Dermatological Drugs Business Revenue (Million USD) of Allergan Inamed Corporation (2013-2018)
Figure Allergan Inamed Corporation Prescription Dermatological Drugs Business Revenue Market Share (2013-2018)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Prescription Dermatological Drugs Market Share by Product in 2017
Table Global Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Global Prescription Dermatological Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Prescription Dermatological Drugs
Figure United States Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure United States Prescription Dermatological Drugs Market Size Share by Players in 2017
Table United States Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure United States Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Europe Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Europe Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Europe Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Europe Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Europe Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure China Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure China Prescription Dermatological Drugs Market Size Share by Players in 2017
Table China Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure China Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Japan Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Japan Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Japan Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Japan Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Players in 2017
Table Southeast Asia Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure India Prescription Dermatological Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Prescription Dermatological Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Prescription Dermatological Drugs Market Size Share by Players in 2013
Figure India Prescription Dermatological Drugs Market Size Share by Players in 2017
Table India Prescription Dermatological Drugs Market Size by Application (2013-2018)
Figure India Prescription Dermatological Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Prescription Dermatological Drugs Market Size Share by Application in 2017
Figure Global Prescription Dermatological Drugs Market Size and Growth Rate (2018-2025)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Regions in 2025
Figure United States Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Prescription Dermatological Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size Share by Type in 2018
Figure Global Prescription Dermatological Drugs Market Size Share by Type in 2025
Table Global Prescription Dermatological Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Prescription Dermatological Drugs Market Size (Million USD) by Application in 2018

Choose License Type